A Pilot Study of a New PEG3350 Dose Formulation For Use in Constipated Children

ClinicalTrials.gov ID: NCT00583609

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00583609. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 12, 2026, 7:32 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the patient acceptance of a new PEG3350 dose formulation in children currently treated with PEG3350 powder for treatment of constipation.

Study identification

NCT ID: NCT00583609
Recruitment status: Completed
Study type: Interventional
Phase: Phase 4
Lead sponsor: Braintree Laboratories; Industry
Enrollment: 20 participants

Conditions and interventions

Conditions

Constipation

Interventions

PEG3350 Drug

Drug

Eligibility (public fields only)

Age range: 4 Years to 16 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2007 (Type not available)
Primary completion: Jul 2008 (Actual)
Completion: Jul 2008 (Actual)
Last update posted: Sep 28, 2009

2007 – 2008

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Not listed	Little Rock	Arkansas	—	—
Not listed	Morristown	New Jersey	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00583609, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Sep 28, 2009 · Synced Nov 12, 2026